EndemicTreponematoses¶
Chapter 188 | Part 5: Infectious Diseases · Part 5 – Infectious Diseases: Bacterial · Chapter 188
Key Clinical Points¶
- Endemic treponematoses (yaws, bejel, pinta) are caused by Treponema pallidum subspecies (pertenue, endemicum, carateum) and differ from venereal syphilis in transmission mode and clinical features.
- Yaws is common in moist tropical areas; bejel in arid climates (West Africa/Middle East); pinta is rare and found in the Americas.
- Leptospirosis is a zoonotic disease (Leptospira species) with rodents as primary reservoirs, often presenting with conjunctival suffusion and potentially progressing to Weil's syndrome.
- Weil's syndrome is characterized by the triad of jaundice, renal dysfunction, and hemorrhagic diathesis; pulmonary hemorrhage is a critical complication.
- Treponematoses diagnosis relies on clinical morphology and serology (RPR/TPPA); NAAT identifies specific subspecies.
- Leptospirosis diagnosis involves a biphasic approach: blood/CSF in acute phase; urine/serology in convalescent phase.
- Yaws treatment: Azithromycin (30 mg/kg) or Benzathine Penicillin G (2.4 million units IM).
- Leptospirosis treatment: Doxycycline (200 mg BID for 7 days), Penicillin G, or Azithromycin; severe cases require IV therapy and organ support.
- Conjunctival suffusion (redness without exudate) is a hallmark of leptospirosis.
- Distinctive clinical markers: 'Crab yaws' (painful papillomatous lesions on soles), bejel mucosal papules, and pinta dyschromic macules.
1. DEFINITION & OVERVIEW¶
• Treponematoses: Chronic, non-venereal infections caused by Treponema pallidum subspecies (pertenue, endemicum, carateum) that differ from syphilis in transmission mode and clinical features. • Leptospirosis: A zoonotic disease caused by pathogenic Leptospira species (over 260 serovars across 26 serogroups) with rodents as primary reservoirs.
1.1 Classification of Treponematoses¶
• Syphilis: T. pallidum subsp. pallidum (Venereal; transmission via sexual/transplacental routes). • Yaws: T. pallidum subsp. pertenue (Moist tropical regions; skin-to-skin contact). • Bejel: T. pallidum subsp. endemicum (Arid climates of West Africa/Middle East; mouth-to-mouth or shared utensils). • Pinta: T. carateum (Temperate Americas; skin-to-skin contact).
Clinical Differentiation Table: | FEATURE | SYPHILIS | YAWS | BEJEL | PINTA | | :--- | :--- | :--- | :--- | :--- | | Organism | T. pallidum s. pallidum | T. pallidum s. pertenue | T. pallidum s. endemicum | T. carateum | | Transmission | Sexual, transplacental | Skin-to-skin | Mouth-to-mouth/shared utensils | Skin-to-skin | | Age of Acquisition | Sexual maturity/in utero | Childhood | Early childhood/adulthood | Late childhood | | Primary Lesion | Mucocutaneous ulcer (chancre) | Papilloma/ulcerative | Mucosal papule | Non-ulcerating papule with satellites | | Secondary Lesions | Cutaneous rash, condylomata lata | Cutaneous papillomatous/ulcerative | Mucocutaneous lesions | Pintides (pigmented macules) | | Late Complications | Gummas, CNS/cardiac involvement | Destructive gummas of skin/bone | Destructive gummas of skin/bone | Nondestructive dyschromic macules |
2. EPIDEMIOLOGY¶
• Yaws: ◦ High prevalence in moist tropical regions. ◦ WHO eradication programs (1952–1969) reduced prevalence from >20% to 10% in parts of Ghana/Senegal, but resurgence occurs in Africa and Pacific Islands. • Bejel & Pinta: ◦ Both are now rare. Bejel is found in arid climates (West Africa/Middle East); Pinta is found in Central/South America. • Leptospirosis: ◦ Global distribution; highest incidence in tropics/subtropics. ◦ Transmission via urine-contaminated water/soil, especially during floods. ◦ Risk factors: Agricultural workers, sewage handlers, fishermen, and urban areas with rodent infestations.
• Treponemal Pathogenesis: ◦ Genetic similarity: Subspecies differ by only ~0.2%. ◦ Immune Response: Requires both humoral (antibodies) and cellular (interferon γ) immunity for healing. ◦ Persistence: Antigenic variation of TprK protein allows immune evasion and persistence. • Leptospiral Pathogenesis: ◦ Entry: Skin or mucosa → Hematogenously disseminate to organs (liver, kidney, brain). ◦ Mechanism: Endothelial activation, thrombocytopenia, and consumptive coagulopathy. ◦ Histopathology: Tubular necrosis, hepatocyte apoptosis, and hemorrhagic infiltration.
4. CLINICAL FEATURES¶
• Yaws: ◦ Primary: Painful papillomatous or ulcerative skin lesions on extremities. ◦ Secondary: Cutaneous/mucosal rash, condylomata lata, osteoperiostitis. ◦ Late: Destructive gummas of skin, bone, and cartilage. • Bejel: ◦ Primary: Mucosal papules (oral/genital). ◦ Secondary: Mucous patches, split papules, condylomata lata. ◦ Late: Destructive gummas of skin and bone. • Pinta: ◦ Primary: Non-ulcerating papule with satellites on extremities/face. ◦ Secondary: Pintides (pigmented macules). ◦ Note: No destructive complications. • Leptospirosis: ◦ Incubation: 5–14 days. ◦ Initial Phase: Fever, headache, myalgia (especially calf), conjunctival suffusion. ◦ Severe Phase (Weil's Syndrome): Jaundice, renal failure, hemorrhage, and pulmonary hemorrhage.
5. DIFFERENTIAL DIAGNOSIS¶
• Treponematoses: ◦ Syphilis (distinguished by sexual transmission). ◦ Leprosy (hypopigmented macules). ◦ Cutaneous leishmaniasis (ulcerative lesions). • Leptospirosis: ◦ Viral hepatitis. ◦ Dengue fever. ◦ Rickettsial infections. ◦ Other hemorrhagic fevers.
6. INVESTIGATIONS & DIAGNOSIS¶
- Treponematoses Identification: • Clinical evaluation of lesions and epidemiology → Differentiation from syphilis. • Serology: RPR and TPPA (same as syphilis). • Specificity: NAAT to identify specific subspecies (pertenue, endemicum, carateum).
- Leptospirosis Identification: • Acute Phase (Leptospiremic): • Blood and CSF → Culture or PCR (preferred for early detection). • Serology: Samples 1 & 2 are acute-phase serum samples. • Convalescent Phase: • Urine → Culture (detects shedding). • Serology: Sample 3 is a convalescent-phase sample (detects delayed immune response). • Follow-up: Samples 4 & 5 provide epidemiologic information, such as the presumptive infecting serogroup.
7. MANAGEMENT & TREATMENT¶
- Treponematoses Treatment: • First-line: Azithromycin (30 mg/kg single dose) OR Benzathine Penicillin G (2.4 million units IM). • Note: Macrolide resistance is emerging in some regions.
- Leptospirosis Treatment: • Mild cases: Doxycycline (200 mg BID for 7 days) OR Azithromycin (500 mg daily). • Severe cases: • IV Penicillin G (18–24 million units/day in divided doses) OR Ceftriaxone. • Support: Management of renal failure, liver failure, and DIC.
8. PROGNOSIS & COMPLICATIONS¶
• Treponematoses: ◦ Early treatment → Prevents late complications (gummas, CNS/cardiac involvement). • Leptospirosis: ◦ Mortality: ~10% in severe cases. ◦ Critical Complications: Pulmonary hemorrhage and renal failure are primary causes of death. ◦ Long-term: Survivors may have persistent renal or hepatic dysfunction.
9. SPECIAL CONSIDERATIONS¶
• Geographic Risk Zones: ◦ Yaws: Sub-Saharan Africa, Pacific Islands. ◦ Bejel: Middle East, West Africa. ◦ Pinta: Central/South America. ◦ Leptospirosis: Global (high in tropics/subtropics). • Occupational Risks: ◦ Farmers, fishermen, sewage workers, and veterinarians.
10. KEY PEARLS & CLINICAL TRAPS¶
• Leptospirosis Hallmark: Conjunctival suffusion (redness without exudate). • Yaws Hallmark: 'Crab yaws' (painful papillomatous lesions on soles). • Pinta Hallmark: Dyschromic macules without destruction. • Bejel Hallmark: Mucosal papules and osteoperiostis. • Diagnostic Timing: Culture/PCR are most effective in blood/CSF during the acute phase; serology is best for convalescent diagnosis.
Reference Tables¶
TABLE 188-1 Classic Comparison of the Agents of the Human Treponematoses and Their Associated Diseases FEATURE Organism…¶
Harrison's 22e, p.1437
| FEATURE | SYPHILIS | YAWS | BEJEL (ENDEMIC SYPHILIS) | PINTA |
|---|---|---|---|---|
| Organism | T. pallidum subsp. pallidum | T. pallidum subsp. pertenue | T. pallidum subsp. endemicum | T. carateum |
| Sexual, transplacental, skin-to-skin | Skin-to-skin | Mouth-to-mouth or via shared drinking/eating utensils, skin to skin, sexuala |
||
| Usual age of acquisition | Sexual maturity or in utero | Childhood | Early childhood, adulthooda | Late childhood |
| Mucocutaneous ulcer (chancre) | Papilloma, often ulcerative | Mucosal papule, rarely seen | ||
| Common location | Genital, oral, anal | Extremities | Oral, occasionally sexuala | Extremities, face |
| Cutaneous rash and mucosal lesions; condylomata lata, ocular and otic syphilis |
Cutaneous papillomatous or ulcerative lesions; condylomata lata, osteoperiostitis |
Mucocutaneous lesions (mucous patch, split papule, condylomata lata); osteoperiostitis |
||
| Infectious relapses | ~25% | Common | Unknown | Unknown |
| Gummas, cardiovascular and central nervous system involvement |
Destructive gummas of skin, bone, cartilageb |
Destructive gummas of skin, bone, cartilageb |